| 原发性硬化性胆管炎诊断及治疗指南(2021) |
| |
| 引用本文： | 中华医学会肝病学分会. 原发性硬化性胆管炎诊断及治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 50-61. DOI: 10.3969/j.issn.1001-5256.2022.01.009 |
| |
| 作者姓名： | 中华医学会肝病学分会 |
| |
| 作者单位： | 空军军医大学第一附属医院消化内科;首都医科大学附属北京友谊医院肝病中心;上海交通大学附属第一人民医院消化内科;上海交通大学医学院附属仁济医院消化内科;河北医科大学第三医院中西医结合肝病科;北京大学第一医院感染疾病科;首都医科大学附属佑安医院肝病中心;北京大学人民医院肝病科;北京大学医学部基础医学院病原生物学系 |
| |
| 摘 要： | 2015年我国第一个原发性硬化性胆管炎(PSC)的专家共识颁布。近年来PSC的临床研究提供了PSC新的研究数据和资料。为此,中华医学会肝病学分会自身免疫性肝病学组组织专家组对近年来的文献证据进行了评估,制定了本指南。本指南共有PSC推荐意见21条。为了利于鉴别PSC和IgG4相关硬化性胆管炎(IgG4-SC),也附有IgG4-SC的10条推荐意见。本指南的目的是为临床PSC和IgG4-SC的诊治提供参考和指导。
|
| 关 键 词： | 原发性硬化性胆管炎 IgG4相关性硬化性胆管炎 诊断 治疗 实践指南 |
Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021) |
| |
| Chinese Society of Hepatology,Chinese Medical Association. Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021)[J]. Chinese Journal of Clinical Hepatology, 2022, 38(1): 50-61. DOI: 10.3969/j.issn.1001-5256.2022.01.009 |
| |
| Authors: | Chinese Society of Hepatology Chinese Medical Association |
| |
| Abstract: | In 2015,the first Chinese consensus on the diagnosis and management of primary sclerosing cholangitis was issued.In the past years,more data have emerged from the literature.Herein,the Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review the evidence and updated the recommendations to formulate the guidelines.There are 21 recommendations on PSC clinical practice.To facilitate the differentiation between PSC and IgG4-related sclerosing cholangitis,10 recommendations on IgG4-SC are also attached.These guidelines aim to provide a working reference for the management of PSC and IgG4-SC. |
| |
| Keywords: | Primary Sclerosing Cholangitis IgG4-related Sclerosing Cholangitis Diagnosis Therapeutics Practice Guideline |
| 本文献已被 维普 万方数据 等数据库收录！ |
